Ligand Pharmaceuticals Inc
NASDAQ:LGND
Income Statement
Earnings Waterfall
Ligand Pharmaceuticals Inc
Revenue
|
131.3m
USD
|
Cost of Revenue
|
-10.5m
USD
|
Gross Profit
|
120.8m
USD
|
Operating Expenses
|
-111m
USD
|
Operating Income
|
9.8m
USD
|
Other Expenses
|
42.3m
USD
|
Net Income
|
52.2m
USD
|
Income Statement
Ligand Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
49
N/A
|
53
+9%
|
54
+2%
|
56
+4%
|
65
+15%
|
63
-2%
|
71
+12%
|
74
+4%
|
72
-2%
|
87
+21%
|
88
+1%
|
92
+4%
|
109
+19%
|
109
0%
|
117
+8%
|
129
+10%
|
141
+10%
|
168
+19%
|
230
+37%
|
242
+5%
|
252
+4%
|
239
-5%
|
174
-27%
|
153
-12%
|
120
-21%
|
110
-9%
|
126
+15%
|
143
+13%
|
186
+30%
|
208
+12%
|
252
+21%
|
275
+9%
|
277
+1%
|
259
-7%
|
231
-11%
|
226
-2%
|
196
-13%
|
188
-4%
|
157
-17%
|
130
-17%
|
131
+1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(6)
|
(8)
|
(8)
|
(6)
|
(9)
|
(8)
|
(9)
|
(9)
|
(6)
|
(6)
|
(4)
|
(4)
|
(6)
|
(5)
|
(5)
|
(7)
|
(5)
|
(6)
|
(6)
|
(5)
|
(6)
|
(9)
|
(11)
|
(12)
|
(11)
|
(12)
|
(17)
|
(21)
|
(30)
|
(34)
|
(57)
|
(62)
|
(62)
|
(59)
|
(40)
|
(43)
|
(53)
|
(52)
|
(41)
|
(30)
|
(11)
|
|
Gross Profit |
43
N/A
|
46
+6%
|
47
+2%
|
50
+6%
|
55
+11%
|
55
+0%
|
62
+12%
|
65
+5%
|
66
+2%
|
81
+23%
|
84
+4%
|
88
+5%
|
103
+17%
|
104
+0%
|
112
+8%
|
122
+9%
|
136
+11%
|
162
+20%
|
224
+38%
|
237
+6%
|
245
+3%
|
229
-6%
|
163
-29%
|
141
-14%
|
109
-22%
|
98
-10%
|
109
+11%
|
123
+13%
|
156
+27%
|
175
+12%
|
195
+12%
|
213
+9%
|
215
+1%
|
200
-7%
|
191
-5%
|
182
-4%
|
143
-21%
|
136
-5%
|
115
-15%
|
100
-14%
|
121
+21%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(27)
|
(29)
|
(30)
|
(33)
|
(35)
|
(36)
|
(40)
|
(37)
|
(38)
|
(41)
|
(44)
|
(52)
|
(59)
|
(65)
|
(64)
|
(63)
|
(68)
|
(67)
|
(72)
|
(78)
|
(81)
|
(89)
|
(97)
|
(103)
|
(115)
|
(113)
|
(113)
|
(118)
|
(147)
|
(165)
|
(147)
|
(152)
|
(136)
|
(123)
|
(161)
|
(156)
|
(140)
|
(98)
|
(79)
|
(74)
|
(111)
|
|
Selling, General & Administrative |
(18)
|
(19)
|
(19)
|
(21)
|
(23)
|
(23)
|
(25)
|
(24)
|
(24)
|
(25)
|
(25)
|
(26)
|
(27)
|
(27)
|
(27)
|
(28)
|
(14)
|
(23)
|
(26)
|
(28)
|
(38)
|
(41)
|
(43)
|
(43)
|
(42)
|
(40)
|
(39)
|
(45)
|
(64)
|
(68)
|
(72)
|
(70)
|
(58)
|
(57)
|
(57)
|
(59)
|
(70)
|
(60)
|
(57)
|
(57)
|
(53)
|
|
Research & Development |
(9)
|
(10)
|
(11)
|
(11)
|
(12)
|
(13)
|
(14)
|
(13)
|
(13)
|
(13)
|
(14)
|
(18)
|
(21)
|
(26)
|
(26)
|
(25)
|
(41)
|
(32)
|
(33)
|
(34)
|
(28)
|
(32)
|
(38)
|
(46)
|
(56)
|
(57)
|
(57)
|
(56)
|
(59)
|
(65)
|
(69)
|
(73)
|
(69)
|
(60)
|
(63)
|
(56)
|
(36)
|
(31)
|
(19)
|
(15)
|
(25)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(3)
|
(6)
|
(8)
|
(11)
|
(11)
|
(11)
|
(11)
|
(12)
|
(13)
|
(13)
|
(16)
|
(16)
|
(16)
|
(16)
|
(14)
|
(17)
|
(17)
|
(17)
|
(18)
|
(23)
|
(32)
|
(40)
|
(48)
|
(47)
|
(44)
|
(44)
|
(41)
|
(34)
|
(29)
|
(26)
|
(25)
|
(34)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
34
|
38
|
38
|
38
|
4
|
0
|
0
|
23
|
23
|
23
|
0
|
|
Operating Income |
16
N/A
|
17
+8%
|
17
-3%
|
17
+2%
|
21
+21%
|
19
-8%
|
22
+16%
|
27
+24%
|
28
+4%
|
40
+42%
|
40
-1%
|
37
-8%
|
45
+23%
|
39
-13%
|
48
+23%
|
59
+23%
|
68
+15%
|
95
+39%
|
152
+60%
|
159
+5%
|
164
+3%
|
140
-14%
|
66
-53%
|
38
-43%
|
(6)
N/A
|
(16)
-175%
|
(4)
+72%
|
4
N/A
|
9
+95%
|
10
+11%
|
48
+400%
|
60
+25%
|
79
+31%
|
76
-3%
|
30
-61%
|
27
-11%
|
3
-89%
|
38
+1 175%
|
37
-4%
|
25
-31%
|
10
-61%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(2)
|
(1)
|
(1)
|
(2)
|
(5)
|
(8)
|
(11)
|
(15)
|
(17)
|
(19)
|
(29)
|
(28)
|
(35)
|
(35)
|
(25)
|
(24)
|
(13)
|
9
|
42
|
103
|
16
|
11
|
(30)
|
(99)
|
(4)
|
(48)
|
(17)
|
(20)
|
(36)
|
6
|
(25)
|
(12)
|
(23)
|
(44)
|
(34)
|
(33)
|
29
|
83
|
91
|
81
|
54
|
|
Non-Reccuring Items |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
27
|
27
|
27
|
27
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
813
|
813
|
813
|
813
|
0
|
0
|
0
|
17
|
12
|
10
|
10
|
(7)
|
(1)
|
3
|
4
|
4
|
4
|
2
|
4
|
2
|
|
Total Other Income |
(4)
|
(5)
|
(7)
|
(8)
|
(4)
|
(1)
|
(8)
|
(3)
|
(3)
|
(4)
|
3
|
(1)
|
(1)
|
0
|
(0)
|
(1)
|
3
|
3
|
(1)
|
(1)
|
(6)
|
(3)
|
(1)
|
(3)
|
(6)
|
(13)
|
(9)
|
(7)
|
(0)
|
(2)
|
(3)
|
(0)
|
(2)
|
1
|
(1)
|
(2)
|
0
|
(2)
|
(3)
|
(8)
|
(2)
|
|
Pre-Tax Income |
9
N/A
|
10
+8%
|
7
-26%
|
6
-15%
|
11
+79%
|
9
-20%
|
30
+232%
|
37
+21%
|
35
-3%
|
45
+27%
|
13
-72%
|
7
-48%
|
8
+22%
|
5
-43%
|
23
+401%
|
34
+47%
|
57
+69%
|
106
+86%
|
194
+82%
|
261
+35%
|
173
-34%
|
961
+454%
|
847
-12%
|
748
-12%
|
797
+6%
|
(77)
N/A
|
(30)
+60%
|
(22)
+27%
|
(11)
+52%
|
26
N/A
|
31
+20%
|
58
+87%
|
47
-18%
|
32
-32%
|
(2)
N/A
|
(4)
-188%
|
36
N/A
|
123
+242%
|
127
+3%
|
103
-19%
|
64
-38%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
191
|
192
|
163
|
167
|
(25)
|
(10)
|
(8)
|
(14)
|
(17)
|
(12)
|
(21)
|
(41)
|
(50)
|
(29)
|
(196)
|
(170)
|
(153)
|
(167)
|
15
|
6
|
6
|
8
|
14
|
17
|
11
|
10
|
(6)
|
(4)
|
(5)
|
(41)
|
(60)
|
(61)
|
(56)
|
(10)
|
|
Income from Continuing Operations |
9
|
10
|
7
|
6
|
11
|
9
|
29
|
228
|
227
|
208
|
180
|
(18)
|
(2)
|
(3)
|
9
|
16
|
45
|
85
|
152
|
211
|
144
|
765
|
677
|
595
|
629
|
(61)
|
(25)
|
(16)
|
(3)
|
39
|
48
|
68
|
57
|
26
|
(6)
|
(10)
|
(5)
|
63
|
66
|
46
|
54
|
|
Income to Minority Interest |
0
|
0
|
0
|
1
|
1
|
2
|
3
|
3
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
11
N/A
|
12
+5%
|
8
-37%
|
7
-9%
|
12
+75%
|
11
-11%
|
33
+206%
|
231
+606%
|
230
0%
|
210
-8%
|
181
-14%
|
(18)
N/A
|
(2)
+91%
|
(3)
-98%
|
9
N/A
|
16
+81%
|
13
-23%
|
53
+319%
|
120
+127%
|
179
+49%
|
143
-20%
|
764
+433%
|
677
-11%
|
594
-12%
|
629
+6%
|
(61)
N/A
|
(25)
+60%
|
(16)
+35%
|
(3)
+81%
|
39
N/A
|
48
+22%
|
68
+43%
|
57
-16%
|
24
-59%
|
(8)
N/A
|
(21)
-167%
|
(33)
-57%
|
24
N/A
|
27
+13%
|
16
-39%
|
52
+216%
|
|
EPS (Diluted) |
0.53
N/A
|
0.55
+4%
|
0.36
-35%
|
0.33
-8%
|
0.56
+70%
|
0.52
-7%
|
1.55
+198%
|
10.74
+593%
|
10.83
+1%
|
9.43
-13%
|
8.66
-8%
|
-0.76
N/A
|
-0.07
+91%
|
-0.13
-86%
|
0.38
N/A
|
0.69
+82%
|
0.53
-23%
|
2.12
+300%
|
4.9
+131%
|
7.43
+52%
|
5.94
-20%
|
35.92
+505%
|
34.6
-4%
|
31.65
-9%
|
31.78
+0%
|
-3.7
N/A
|
-1.47
+60%
|
-0.99
+33%
|
-0.18
+82%
|
2.27
N/A
|
2.78
+22%
|
4
+44%
|
3.31
-17%
|
1.4
-58%
|
-0.47
N/A
|
-1.24
-164%
|
-1.97
-59%
|
1.33
N/A
|
1.53
+15%
|
0.94
-39%
|
2.93
+212%
|